10/02/2026
🛡️ Spotting the warning signs can help prevent patient harm. At the Johns Hopkins Bloomberg School of Public Health BESAFE 2026 conference, ISMP President Rita Jew joined Henry Michtalik, Douglas Braun, and Clarence Lam on the panel "Blind Spots in Practice: Uncovering What Providers Miss About Substandard and Falsified Medicines." Together, they explored how healthcare providers can better recognize and respond to suspect medical products.
Key takeaways from Rita's presentation include:
🔹 Watch for red flags such as unusual packaging and labeling, ability to purchase online without prescription, and no licensed pharmacist available to answer questions.
🔹 Ask patients where they obtain their medications and discuss risks associated with illegal online pharmacies.
🔹 Consider substandard or falsified medicines as possible culprit when medications aren't working as expected or patients experience unexpected outcomes.
🔹 Develop mitigation strategies for known problem drugs such as GLP1 agonists.
🔹 Report concerns and suspicious products to help strengthen surveillance efforts and protect patients from harm.
Learn more about the fight against substandard and falsified medical products: https://hubs.la/Q04z1CDR0
Additional ISMP tips: https://hubs.la/Q04z1CGB0